The Neurology Ionis Young Investigator Grant funds early-career researchers advancing innovative research on Angelman Syndrome, supported by Ionis Pharmaceuticals.
FAST's New Investigator Award funds early-career researchers launching translational science projects focused on Angelman syndrome.
FAST’s New Investigator award funds early-career researchers advancing translational science and therapeutic innovation for Angelman syndrome.
Ionis Pharmaceuticals' Investigator‑Initiated Research Program funds independent studies advancing science in cardiovascular, hereditary angioedema, and neurological diseases.
The FAST Impact Award funds innovative translational research to advance therapies for Angelman syndrome from pre-clinical stages to IND application readiness.